Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Caffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cells
Natasa Dragicevic, Vedad Delic, Chuanhai Cao, et al.
Neuropharmacology (2012) Vol. 63, Iss. 8, pp. 1368-1379
Closed Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin's primary function and evolution in eukaryotes
Dun‐Xian Tan, Lucien C. Manchester, Xiaoyan Liu, et al.
Journal of Pineal Research (2012) Vol. 54, Iss. 2, pp. 127-138
Open Access | Times Cited: 527
Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption
Astrid Nehlig
Pharmacological Reviews (2018) Vol. 70, Iss. 2, pp. 384-411
Open Access | Times Cited: 522
Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?
Simone Cappelletti, Daria Piacentino, Gabriele Sani, et al.
Current Neuropharmacology (2014) Vol. 13, Iss. 1, pp. 71-88
Open Access | Times Cited: 502
Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer’s Disease and Late-Life Cognitive Disorders: A Systematic Review
Vincenzo Solfrizzi, Carlo Custodero, Madia Lozupone, et al.
Journal of Alzheimer s Disease (2017) Vol. 59, Iss. 3, pp. 815-849
Closed Access | Times Cited: 317
The neuroprotective effects of caffeine in neurodegenerative diseases
Mahshad Kolahdouzan, Mazen J. Hamadeh
CNS Neuroscience & Therapeutics (2017) Vol. 23, Iss. 4, pp. 272-290
Open Access | Times Cited: 248
Mitochondria as Potential Targets in Alzheimer Disease Therapy: An Update
Giovanna Cenini, Wolfgang Voos
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 213
Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: A review
Marla Rivera-Oliver, Manuel Díaz‐Ríos
Life Sciences (2014) Vol. 101, Iss. 1-2, pp. 1-9
Open Access | Times Cited: 193
Melatonin: Clinical Perspectives in Neurodegeneration
Daniel P. Cardinali
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 164
Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: A systematic review
Francesco Panza, Vincenzo Solfrizzi, Maria Rosaria Barulli, et al.
The journal of nutrition health & aging (2014) Vol. 19, Iss. 3, pp. 313-328
Open Access | Times Cited: 181
Signaling pathway cross talk in Alzheimer’s disease
Juan A. Godoy, Juvenal A. Ríos, Juan M. Zolezzi, et al.
Cell Communication and Signaling (2014) Vol. 12, Iss. 1
Open Access | Times Cited: 152
Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases
Shuqing Chen, Wang Ze-shi, Yixiao Ma, et al.
Molecules (2018) Vol. 23, Iss. 3, pp. 512-512
Open Access | Times Cited: 110
Health benefits of methylxanthines in neurodegenerative diseases
Ainhoa Oñatibia‐Astibia, Rafael Franco, Eva Martínez‐Pinilla
Molecular Nutrition & Food Research (2017) Vol. 61, Iss. 6
Closed Access | Times Cited: 95
Potential of Caffeine in Alzheimer’s Disease—A Review of Experimental Studies
Piotr Londzin, Milena Zamora, Beata Kąkol, et al.
Nutrients (2021) Vol. 13, Iss. 2, pp. 537-537
Open Access | Times Cited: 60
Antioxidants: an approach for restricting oxidative stress induced neurodegeneration in Alzheimer’s disease
Sonal Dubey, Ekta Singh
Inflammopharmacology (2023) Vol. 31, Iss. 2, pp. 717-730
Closed Access | Times Cited: 25
Mitochondria-Targeted Protective Compounds in Parkinson’s and Alzheimer’s Diseases
Carlos Fernández‐Moriano, Elena González‐Burgos, M. Pilar Gómez‐Serranillos
Oxidative Medicine and Cellular Longevity (2015) Vol. 2015, pp. 1-30
Open Access | Times Cited: 86
Pharmacological potential of methylxanthines: Retrospective analysis and future expectations
João P. Monteiro, Marco G. Alves, Pedro F. Oliveira, et al.
Critical Reviews in Food Science and Nutrition (2018) Vol. 59, Iss. 16, pp. 2597-2625
Open Access | Times Cited: 77
Differential effects of caffeine on hair shaft elongation, matrix and outer root sheath keratinocyte proliferation, and transforming growth factor‐β2/insulin‐like growth factor‐1‐mediated regulation of the hair cycle in male and female human hair folliclesin vitro
Tobias W. Fischer, Erika Herczeg-Lisztes, Wolfang Funk, et al.
British Journal of Dermatology (2014) Vol. 171, Iss. 5, pp. 1031-1043
Open Access | Times Cited: 70
Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases
Robert B. Cameron, Craig C. Beeson, Rick G. Schnellmann
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 23, pp. 10411-10434
Open Access | Times Cited: 63
Relationship of the Phytochemicals from Coffee and Cocoa By-Products with their Potential to Modulate Biomarkers of Metabolic Syndrome In Vitro
Miguel Rebollo‐Hernanz, Qiaozhi Zhang, Yolanda Aguilera, et al.
Antioxidants (2019) Vol. 8, Iss. 8, pp. 279-279
Open Access | Times Cited: 58
Exploring the multifunctional role of melatonin in regulating autophagy and sleep to mitigate Alzheimer’s disease neuropathology
Md. Farhad Hossain, Ni Wang, Ruijun Chen, et al.
Ageing Research Reviews (2021) Vol. 67, pp. 101304-101304
Closed Access | Times Cited: 44
Mitochondrial Modulators: The Defender
Emmanuel Ayobami Makinde, Linlin Ma, George D. Mellick, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 226-226
Open Access | Times Cited: 17
Protective roles of melatonin against the amyloid-dependent development of Alzheimer’s disease: A critical review
Bruno Vincent
Pharmacological Research (2018) Vol. 134, pp. 223-237
Closed Access | Times Cited: 51
Adenosine receptors as a new target for resveratrol-mediated glioprotection
Larissa Daniele Bobermin, Ricardo Haack Amaral Roppa, André Quincozes‐Santos
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2019) Vol. 1865, Iss. 3, pp. 634-647
Closed Access | Times Cited: 48
An outlook on the role of decaffeinated coffee in neurodegenerative diseases
Raffaella Colombo, Adele Papetti
Critical Reviews in Food Science and Nutrition (2019) Vol. 60, Iss. 5, pp. 760-779
Closed Access | Times Cited: 43
Bioactive Compounds and Traditional Herbal Medicine: Promising Approaches for the Treatment of Dementia
Nafaa Alzobaidi, Huma Quasimi, Nasr A. Emad, et al.
Degenerative Neurological and Neuromuscular Disease (2021) Vol. Volume 11, pp. 1-14
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top